A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.

Saved in:
Bibliographic Details
Title: A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.
Authors: Gettinger SN; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA., Choi J; Department of Genetics, Yale School of Medicine, New Haven, CT, 06511, USA., Mani N; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.; Translational Immuno-oncology Laboratory, Yale Cancer Center, New Haven, CT, 06511, USA., Sanmamed MF; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA., Datar I; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA.; Translational Immuno-oncology Laboratory, Yale Cancer Center, New Haven, CT, 06511, USA., Sowell R; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA., Du VY; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA., Kaftan E; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA.; Translational Immuno-oncology Laboratory, Yale Cancer Center, New Haven, CT, 06511, USA., Goldberg S; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA., Dong W; Department of Genetics, Yale School of Medicine, New Haven, CT, 06511, USA., Zelterman D; Yale School of Public Health, New Haven, CT, 06511, USA., Politi K; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA.; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA., Kavathas P; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA.; Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06511, USA., Kaech S; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA., Yu X; Yale School of Public Health, New Haven, CT, 06511, USA., Zhao H; Department of Genetics, Yale School of Medicine, New Haven, CT, 06511, USA.; Yale School of Public Health, New Haven, CT, 06511, USA., Schlessinger J; Department of Pharmacology, Yale School of Medicine, New Haven, CT, 06511, USA., Lifton R; Department of Genetics, Yale School of Medicine, New Haven, CT, 06511, USA., Rimm DL; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA.; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA., Chen L; Immunobiology, Yale School of Medicine, New Haven, CT, 06511, USA., Herbst RS; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA., Schalper KA; Medical Oncology and Yale Cancer Center, New Haven, CT, 06511, USA. kurt.schalper@yale.edu.; Department of Pathology, Yale School of Medicine, New Haven, CT, 06511, USA. kurt.schalper@yale.edu.; Translational Immuno-oncology Laboratory, Yale Cancer Center, New Haven, CT, 06511, USA. kurt.schalper@yale.edu.
Source: Nature communications [Nat Commun] 2018 Aug 10; Vol. 9 (1), pp. 3196. Date of Electronic Publication: 2018 Aug 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-018-05032-8